SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jiangang Pan, Mo Liu, Xing Zhou, Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis, Frontiers of Medicine, 2014, 8, 2, 241

    CrossRef

  2. 2
    Ashish M. Kamat, J. Alfred Witjes, Maurizio Brausi, Mark Soloway, Donald Lamm, Raj Persad, Roger Buckley, Andreas Böhle, Marc Colombel, Joan Palou, Defining and Treating the Spectrum of Intermediate Risk Nonmuscle Invasive Bladder Cancer, The Journal of Urology, 2014, 192, 2, 305

    CrossRef

  3. 3
    Donald Lamm, Maurizio Brausi, Michael A. O'Donnell, J. Alfred Witjes, Interferon alfa in the treatment paradigm for non–muscle-invasive bladder cancer, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 1, 35.e21

    CrossRef

  4. 4
    Ashish M. Kamat, Sima Porten, Myths and Mysteries Surrounding Bacillus Calmette-Guérin Therapy for Bladder Cancer, European Urology, 2014, 65, 2, 267

    CrossRef

  5. You have free access to this content5
    Samer Jallad, Stephanie Goubet, Andrew Symes, Timothy Larner, Philip Thomas, Prognostic value of inflammation or granuloma after intravesival BCG in non-muscle-invasive bladder cancer, BJU International, 2014, 113, 5b
  6. 6
    Takehiko Okamura, Ryosuke Ando, Hidetoshi Akita, Noriyasu Kawai, Keiichi Tozawa, Kenjiro Kohri, Hideo Arano, Prophylactic effects of Bacille Calmette-Guérin intravesical instillation therapy: Time period-related comparison between Japan and Western countries, Current Urology Reports, 2014, 15, 1

    CrossRef

  7. 7
    Donald L. Lamm, Nilay M. Gandhi, Re: Behfar Ehdaie, Richard Sylvester, Harry W. Herr. Maintenance Bacillus Calmette-Guérin Treatment of Non–Muscle-invasive Bladder Cancer: A Critical Evaluation of the Evidence. Eur Urol 2013;64:579–85, European Urology, 2014, 65, 1, e6

    CrossRef

  8. 8
    Koji Kawai, Jun Miyazaki, Akira Joraku, Hiroyuki Nishiyama, Hideyuki Akaza, Bacillus Calmette–Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine, Cancer Science, 2013, 104, 1
  9. 9
    Friedrich-Carl von Rundstedt, Seth P. Lerner, Bladder cancer: Always consider extravesical sites when BCG fails, Nature Reviews Urology, 2013, 11, 1, 11

    CrossRef

  10. 10
    J. Alfred Witjes, Joan Palou, Mark Soloway, Donald Lamm, Ashish M. Kamat, Maurizio Brausi, Raj Persad, Roger Buckley, Marc Colombel, Andreas Böhle, Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS), BJU International, 2013, 112, 6
  11. 11
    Jorg Oddens, Maurizio Brausi, Richard Sylvester, Aldo Bono, Cees van de Beek, George van Andel, Paolo Gontero, Wolfgang Hoeltl, Levent Turkeri, Sandrine Marreaud, Sandra Collette, Willem Oosterlinck, Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance, European Urology, 2013, 63, 3, 462

    CrossRef

  12. 12
    Behfar Ehdaie, Richard Sylvester, Harry W. Herr, Maintenance Bacillus Calmette-Guérin Treatment of Non–muscle-invasive Bladder Cancer: A Critical Evaluation of the Evidence, European Urology, 2013, 64, 4, 579

    CrossRef

  13. 13
    A 2-week Maintenance Regimen of Intravesical Instillation of Bacillus Calmette-Guerin is Safe, Adherent and Effective in Patients with Non-muscle-invasive Bladder Cancer: A Prospective, Multicenter Phase II Clinical Trial, Japanese Journal of Clinical Oncology, 2012, 42, 9, 813

    CrossRef

  14. 14
    M. Onozawa, N. Miyanaga, S. Hinotsu, J. Miyazaki, T. Oikawa, T. Kimura, E.-i. Takaoka, K. Kawai, T. Shimazui, H. Sakurai, H. Nishiyama, H. Akaza, Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer, Japanese Journal of Clinical Oncology, 2012, 42, 9, 825

    CrossRef

  15. 15
    Takehiko Okamura, Ryosuke Ando, Hidetoshi Akita, Yoshihiro Hashimoto, Yutaka Iwase, Taku Naiki, Noriyasu Kawai, Keiichi Tozawa, Kenjiro Kohri, Are there Time-period-related Differences in the Prophylactic Effects of Bacille Calmette-Guérin Intravesical Instillation Therapy in Japan?, Asian Pacific Journal of Cancer Prevention, 2012, 13, 9, 4357

    CrossRef

  16. 16
    Willem Oosterlinck, Karel Decaestecker, Current strategies in the treatment of non-muscle-invasive bladder cancer, Expert Review of Anticancer Therapy, 2012, 12, 8, 1097

    CrossRef

  17. 17
    Ja H. Ku, Seth P. Lerner, Strategies to prevent progression of high-risk bladder cancer at initial diagnosis, Current Opinion in Urology, 2012, 22, 5, 405

    CrossRef